Epilepsy clinical trials at UCSF
5 in progress, 1 open to new patients

• Clinical Utility of Pediatric Whole Exome Sequencing

  open to eligible people ages up to 18 years

  The investigator aims to examine the clinical utility of WES, including assessment of a variety of clinical outcomes in undiagnosed pediatric cases.

  Oakland, California and other locations

• Human Epilepsy Project 2: Resistant Focal Seizures Study

  Sorry, not currently recruiting here

  The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 205 people with medication-resistant focal epilepsy over two years to measure changes in health status, healthcare costs, quality of life, and biomarkers of epilepsy severity and treatment response.

  San Francisco, California and other locations

• RNS® System Epilepsy PAS

  Sorry, accepting new patients by invitation only

  The purpose of the study is to follow patients with partial onset seizures prospectively over 5 years in the real-world environment to gather data on the long-term safety and effectiveness of the RNS System at qualified CECs by qualified neurologists, epileptologists, and neurosurgeons trained on the RNS System.

  San Francisco, California and other locations

• Stereotactic Laser Ablation for Temporal Lobe Epilepsy

  Sorry, not currently recruiting here

  The study is designed to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for mesial temporal epilepsy (MTLE).

  San Francisco, California and other locations

• The Human Epilepsy Project

  Sorry, in progress, not accepting new patients

  HEP is a five-year, prospective, observational study whose primary goal is to identify clinical characteristics and biomarkers predictive of disease outcome, progression, and treatment response in participants with newly treated focal epilepsy.

  San Francisco, California and other locations

Last updated: October 25, 2018